Section Arrow
Quote
GLMD.NASDAQ
- Galmed Pharmaceuticals Ltd
(Financial Status)
Quotes are at least 15-min delayed:2026/02/23 15:52 EST
After Hours
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 0.550101
+0.009101 (+1.68%)
Day High 
0.5771 
Prev. Close
0.541 
1-M High
0.8721 
Volume 
167.51K 
Bid
0.55
Ask
0.5773
Day Low
0.5025 
Open
0.54 
1-M Low
0.54 
Market Cap 
3.56M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.62 
20-SMA 0.67 
50-SMA 0.79 
52-W High 3.5 
52-W Low 0.54 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.44/-0.55
Enterprise Value
3.56M
Balance Sheet
Book Value Per Share
2.90
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
GOSSGossamer Bio0.4259-1.7041-80.00%-- 
After Hours -- -- --
IBRXImmunityBio9.715+1.015+11.67%-- 
After Hours -- -- --
VNDAVanda Pharmaceuticals8.195+2.435+42.27%-- 
After Hours -- -- --
IKTInhibikase Therapeutics1.885+0.125+7.10%3.74PE
After Hours -- -- --
ACLXArcellx113.815+49.705+77.53%-- 
After Hours -- -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.